The Socioeconomic Burden of Pulmonary Arterial Hypertension in Canada
This survey was conducted by the Pulmonary Hypertension Association of Canada and the Canadian VIGOUR Centre, an academic research organization at the University of Alberta, on behalf of a pharmaceutical company. The purpose of this study was to learn about how pulmonary arterial hypertension impacts your work and daily living activities. We wanted to identify how pulmonary arterial hypertension (PAH) affects your daily life, which may be useful in estimating the benefits of new treatments. This study was an opportunity for you to tell us how PAH affects your daily activities, work productivity, and career opportunities.
A comprehensive report detailing the outcomes of this survey is available on our Burden of Illness Survey Reports page.
Principal Investigator: Dr. Jason Weatherald, University of Alberta
Contact Information: If you have any questions or require more information about the study itself, you may contact the researcher at weathera@ualberta.ca.
REB ID (Pro00130718)